Ramdev Gets A Week To Reply To Doctors’ Lawsuit

New Delhi : The Delhi High Court Friday gave yoga guru Ramdev a week to reply to an application by doctors’ associations for instituting a lawsuit against him for his statements on allopathy during the pandemic.

The lawsuit falls under Section 91 of the Code of Civil Procedure that deals with “public nuisance or any other wrongful act affecting or likely to affect the public”. It can be instituted only by an Advocate General or with leave from a court.

The Residents Doctors’ Association of All India Institute of Medical Science, Rishikesh and other unions representing the medicos in the lawsuit have sought a permanent and mandatory injunction against his “mala fide misinformation campaign” against allopathy. They have contended such “misinformation campaign” during the ongoing pandemic has the propensity to divert people from allopathic treatments. The case will be heard on August 10.

  • Related Posts

    LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

    Phase 2 results for LB-102 showed statistically significant reductions in PANSS total score across all doses with onset by week 1 and sustained through study end, alongside low rates of…

    Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

    After substandard drug manufacturing, the state drug firms are once again under the scanner of the central government for manufacture and sale of unapproved fixed dose combination (FDC) drugs which…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

    LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

    Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

    Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

    Stem cell therapy for autism illegal: NMC advisory

    Stem cell therapy for autism illegal: NMC advisory

    India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework

    India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework

    Delhi HC Asks Dr Reddy’s To Halt Olymviq Sales; Flags Similarity With Novo Nordisk’s Ozempic

    Delhi HC Asks Dr Reddy’s To Halt Olymviq Sales; Flags Similarity With Novo Nordisk’s Ozempic

    NPPA allows 0.64% hike in MRP of essential drugs in line with WPI rise

    NPPA allows 0.64% hike in MRP of essential drugs in line with WPI rise